Research map: Transcriptional modulation of the PI3K/AKT/mTOR signaling pathway mediated by HPV16 E5, E6, and E7 oncogene expression in breast cancer

Back to the article

Papers in this map

  1. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method · Kenneth J. Livak · 2001 · 185110 citations · Cited by this paper
  2. HPV-associated breast cancer: Insights into molecular and epigenetic alterations · Vanessa Emanuelle Pereira Santos · 2026 · Cites this paper
  3. Emerging roles of haemostatic proteins as markers of disease progression and prognosis in breast cancer · 2026 · Related
  4. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries · Freddie Bray · 2024 · 26051 citations · Cited by this paper
  5. FDA 2025 Cancer Drug Approvals: targeted therapy dominates · 2026 · Related
  6. Silhouettes: A graphical aid to the interpretation and validation of cluster analysis · Peter J. Rousseeuw · 1987 · 21846 citations · Cited by this paper
  7. Racial disparities in hepatocellular carcinoma: a TCGA-based gene expression study of Caucasian and Asian populations · 2025 · Related
  8. mTOR Signaling in Growth, Metabolism, and Disease · Robert A. Saxton · 2017 · 7778 citations · Cited by this paper
  9. Metabolic plasticity drives specific mechanisms of chemotherapy and targeted therapy resistance in metastatic colorectal cancer · 2025 · Related
  10. Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor · Anne Sophie Brunet · 1999 · 6636 citations · Cited by this paper
  11. Benign, persistent, and invasive: mechanistic and translational approaches to middle‑ear cholesteatoma · 2026 · Related
  12. Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer · José Baselga · 2011 · 2874 citations · Cited by this paper
  13. Lorlatinib in advanced ALK-positive NSCLC after prior progression on ALK inhibitors: real-world experience in Russia · 2026 · Related
  14. Risk Factors and Preventions of Breast Cancer · Yi-Sheng Sun · 2017 · 2055 citations · Cited by this paper
  15. Reactive oxygen species (ROS) in cancer: from redox signaling and metabolic plasticity to therapeutic vulnerabilities · 2026 · Related
  16. Biological subtypes of breast cancer: Prognostic and therapeutic implications · Özlem Yersal · 2014 · 1192 citations · Cited by this paper
  17. Liquid biopsy in breast cancer: current biomarker platforms and clinical applications · 2026 · Related
  18. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease · Vivek Panwar · 2023 · 961 citations · Cited by this paper
  19. More than alternative estrogen receptors: the emerging role of GPER-1 and ERα36 in breast cancer · 2026 · Related
  20. PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects · Daniela Miricescu · 2020 · 881 citations · Cited by this paper
  21. CHD4 and NOX4 expression in thyroid tumor tissues · 2026 · Related
  22. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis · Cathy Ndiaye · 2014 · 742 citations · Cited by this paper
  23. Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors · Dima A. Sabbah · 2020 · 601 citations · Cited by this paper
  24. PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment · Ángel Guerrero Zotano · 2016 · 446 citations · Cited by this paper
  25. EGFR-TKIs resistance via EGFR-independent signaling pathways · Qian Liu · 2018 · 407 citations · Cited by this paper
  26. A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer · Léa Clusan · 2023 · 377 citations · Cited by this paper
  27. Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus · Pengda Liu · 2014 · 372 citations · Cited by this paper
  28. High EGFR gene copy number predicts poor outcome in triple-negative breast cancer · Heae Surng Park · 2014 · 305 citations · Cited by this paper
  29. Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy · Qingfang Li · 2022 · 271 citations · Cited by this paper
  30. The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses · Lifang Zhang · 2015 · 266 citations · Cited by this paper
  31. AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? · Federica Martorana · 2021 · 234 citations · Cited by this paper
  32. Efficacy of PI3K inhibitors in advanced breast cancer · B. Verret · 2019 · 222 citations · Cited by this paper
  33. Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer · Thanakorn Pungsrinont · 2021 · 217 citations · Cited by this paper
  34. Emerging role of PTEN loss in evasion of the immune response to tumours · Thiago Vidotto · 2020 · 215 citations · Cited by this paper
  35. The Human Papillomavirus Type 16 E6 Oncoprotein Activates mTORC1 Signaling and Increases Protein Synthesis · Jennifer Marie Spangle · 2010 · 203 citations · Cited by this paper
  36. PI3K mutations in breast cancer: prognostic and therapeutic implications · Toru Mukohara · 2015 · 199 citations · Cited by this paper
  37. Identification of a Role for the PI3K/AKT/mTOR Signaling Pathway in Innate Immune Cells · Songbo Xie · 2014 · 181 citations · Cited by this paper
  38. Human papillomavirus in breast cancer · Anna Di Lonardo · 1992 · 155 citations · Cited by this paper
  39. PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies · Menglei Jin · 2024 · 144 citations · Cited by this paper

Source: OpenAlex (CC0)